Rebecca Bungay
Toronto, ON M5X1A9, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Patient-reported time toxicity with bispecific antibody therapies in relapsed/refractory follicular lymphoma and diffuse large B-cell lymphoma.
Journal: The oncologist
Published: February 18, 2026
Rifaximin reduces rehospitalization risk in patients with cirrhosis and overt hepatic encephalopathy.
Journal: Hepatology communications
Published: July 10, 2025
Agitation in individuals with Alzheimer's disease: An assessment of behaviors using the cohen-mansfield agitation inventory in community-dwellers and impact on caregiver experience.
Journal: Dementia (London, England)
Published: May 14, 2025
Health care resource utilization and costs associated with psychiatric comorbidities in adult patients with attention-deficit/hyperactivity disorder.
Journal: Journal of managed care & specialty pharmacy
Published: June 02, 2024
Costs associated with adverse events during treatment episodes for adult attention-deficit/hyperactivity disorder.
Journal: Journal of medical economics
Published: April 11, 2024
Real-world clinical outcomes and healthcare costs in patients with Crohn's disease treated with vedolizumab versus ustekinumab in the United States.
Journal: Current medical research and opinion
Published: April 08, 2024
A real-world assessment of healthcare costs associated with agitation in Alzheimer's dementia.
Journal: Journal of medical economics
Published: December 11, 2023
Treatment-Free Interval: A Novel Approach to Assessing Real-World Treatment Effectiveness and Economic Impact Among Patients with Irritable Bowel Syndrome with Diarrhea.
Journal: Advances in therapy
Published: November 16, 2023
Healthcare resource utilization and costs associated with psychiatric comorbidities in pediatric patients with attention-deficit/hyperactivity disorder: a claims-based case-cohort study.
Journal: Child and adolescent psychiatry and mental health
Published: October 13, 2023
Impact of rifaximin use following an initial overt hepatic encephalopathy hospitalization on rehospitalization and costs.
Journal: Journal of medical economics
Published: September 04, 2023
Economic burden of invasive Escherichia coli disease among older adult patients treated in hospitals in the United States.
Journal: Journal of managed care & specialty pharmacy
Published: July 31, 2023
Last Updated: 09/26/2026